梗阻性黄疸介入治疗的临床价值(附30例分析)  

Treatment of biliary obstruction by percutaneous transhepatic insertion of metallic stent and PTCD(analysis of 30 cases)

作　　者：袁国超[1] 李京雨[1] 徐立扬[1] 邹志孟 

机构地区：[1]北京军区总医院放射科,北京100700 [2]山东省烟台牟平人民医院放射科,山东烟台264100

出　　处：《医学影像学杂志》2001年第2期87-88,共2页Journal of Medical Imaging

摘　　要：目的 :探讨梗阻性黄疸介入治疗的临床价值。方法 :30例梗阻性黄疸患者在经皮穿刺胆道造影后进行介入治疗 ,其中PTCD19例 ,PTCD +胆道内支架 11例 ,共使用金属支架 16枚。结果 :全组技术成功率 10 0 % ,其中 2 8例 (占 93 .3 % )黄疸消退满意 ,治疗前后血清总胆红素相差的均数±标准误差为 2 0 5 .3± 93.4μmol/L ,P <0 .0 1,直接胆红素相差的均数±标准误差为 133 .8± 5 7.1μmol/L ,P <0 .0 1。2例因梗阻复杂及术后胆道感染 ,效果不满意。全组 30天病死率 3 .3 %(1/30 )。结论Objective:To study the clinical value of PTCD and percutaneous transhepatic insertion of biliary stent(PTIBS)for treating malignant and benign biliary obstruction. Methods:Thirty patients with biliary obstruction were treated by PTIBS and PTCD.A total of 16 biliary metallic stents were placed in 11 patients with biliary obstruction.19 cases were treated by PTCD.[WT5”HZ]Results:[WT5”BZ]The technical success rate was 100%(30/30).In 28 cases (93.3%),jaundice was reduced satisfactorily.The difference between post-and ante-operation in the serum total bilirubin level of 28 patients was unsatisfactory.The 30-day mortality rate was 3.3%(1/30).Conclusion:PTIBS and PTCD were effective and safe method in the treatment of biliary obstruction.

关 键 词：内支架 胆管阻塞 肝外胆管肿瘤 梗阻性黄疸 介入治疗 

分 类 号：R657.4[医药卫生—外科学] R735.8[医药卫生—临床医学]